Skip to search formSkip to main contentSkip to account menu

Adenovirus serotype

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Airway Delivery of an Adenovirus-Based Ebola Virus Vaccine Bypasses Existing Immunity to Homologous Adenovirus in Nonhuman Primates
ABSTRACT Anti-adenovirus serotype 5 antibodies are capable of neutralizing adenovirus serotype 5-based vaccines. In mice and… 
2010
2010
An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood
Polyethylene glycol coating (PEGylation) of adenovirus serotype 5 (Ad5) has been shown to effectively reduce immunogenicity and… 
Highly Cited
2009
Highly Cited
2009
Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors.
Highly Cited
2008
Highly Cited
2008
Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo
Human species C adenovirus serotype 5 (Ad5) is the most common viral vector used in clinical studies worldwide. Ad5 vectors… 
Review
2008
Review
2008
Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35.
The capacity of gene delivery vehicles is considered to be a critical factor determining the success of gene therapy. To date… 
2006
2006
Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice
We previously demonstrated that systemic administration of adenovirus serotype 35 (Ad35) vectors to mice does not mediate… 
Highly Cited
2005
Highly Cited
2005
Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity
ABSTRACT The high prevalence of preexisting immunity to adenovirus serotype 5 (Ad5) in human populations will likely limit the… 
Highly Cited
2005
Highly Cited
2005
Immunogenicity of Recombinant Fiber-Chimeric Adenovirus Serotype 35 Vector-Based Vaccines in Mice and Rhesus Monkeys
ABSTRACT Preexisting immunity to adenovirus serotype 5 (Ad5) has been shown to suppress the immunogenicity of recombinant Ad5… 
Highly Cited
2004
Highly Cited
2004
Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors
ABSTRACT The high prevalence of preexisting immunity to adenovirus serotype 5 (Ad5) in human populations will likely limit the… 
Review
1990
Review
1990
Adenoviruses as expression vectors and recombinant vaccines.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)